[Therapeutic studies in experimental aureomycin-activated moniliasis].
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000904:Antibiotics, Antitubercular; D002177:Candidiasis; D002751:Chlortetracycline; D003879:Dermatologic Agents; D013440:Sulfides / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D013440:Sulfides; D002751:Chlortetracycline
ANTIBIOTICS/effects; MONILIASIS/experimental; SULFIDES/effects
Therapieversuche bei der experimentellen aureomycinaktivierten Soorinfektion.